Ascletis Received IND Approval for its NASH Drug
Ascletis Pharma Inc. (1672.HK), an innovative R&D...
Read MoreAscletis Pharma Inc. (1672.HK), an innovative R&D...
Read MoreLineage Cell Therapeutics, Inc. (NYSE...
Read MoreLEO Pharma, a global leader...
Read MoreGlaxoSmithKline has licensed Ionis Pharmaceuticals’...
Read MoreAstraZeneca today announced that the...
Read MoreCantargia and BioWa have signed...
Read MoreThe World Neurosciences Summit organised...
Read MoreVigilance Department and Anti-Corruption Bureau...
Read MoreDrug firm Lupin’s South African...
Read MoreDrug firm Granules India on...
Read More